Dr. Dana York is a distinguished educator and researcher specializing in dentistry and laser technology. With degrees from institutions like Carol Davila University and New York University, she has contributed significantly to the field through teaching, research, and clinical practice. Dr. York's expertise extends globally, including roles as a Clinical Assistant Professor at New York University and as President of the European Medical Laser Association. Her research, focused on laser therapy and periodontal regeneration, has earned her numerous awards and recognitions, including Best Paper Awards at prestigious conferences. Beyond her professional endeavors, Dr. York is actively involved in charitable organizations and is a talented artist and pianist.

Andrew Macnab is a Professor in the faculty of medicine at the University of British Columbia, Vancouver, Canada and a Fellow of the Stellenbosch Institute for Advanced Study (STIAS) at Stellenbosch University, South Africa. Highly respected as a clinician, he is also an award-winning researcher with a reputation for innovation and excellence. Many of his initiatives involving novel educational approaches and application of leading-edge technology to improve health care delivery have been adopted nationally and internationally. He has > 50 years experience developing, delivering and evaluating global health projects that provide health education, engage communities, and improve access to health care; recent funding includes Grand Challenges Canada programs in Africa and Afghanistan. He is an world authority on the use of the WHO Health Promoting School model to engage and inform youth; a unique model with global potential for educating the next generation of parents on the role of vaccines. He is the team lead, for the STIAS African Scholars Network, and author of the network’s inaugural publication in The Lancet Global Health, ‘Making Covid-19 vaccine acceptance strategies culturally relevant in sub-Saharan Africa.’ Currently he divides his time between his research programsin Canada, global health projects in Africa and Indonesia that promote child and family health, educational strategies intended to inform and engage new parentsin preventive health, and mentorship of the next generation of health care providers.

Anh Wartel, MD, is the Deputy Director General and Regional Director of the IVI Europe Regional Office, overseeing the European Offices' operational, scientific, and technical activities. She is based in Stockholm, Sweden.Dr. Anh Wartel joined IVI in 2018 as the Head of Clinical Development and Regulatory, then the Deputy Director General of the CARE Unit.Before IVI, Dr. Anh Wartel held various positions in Epidemiology, Clinical R&D, and Medical Affairs, overseeing multiple clinical developments (e.g., rabies, cholera, typhoid fever, hepatitis A, yellow fever, dengue, Japanese encephalitis vaccines) in pre- and post-licensure stages at Sanofi in Asia for fifteen years. She initially started her research career with the French National Agency of Research on HIV/AIDS (ANRS), involved in drug trial projects as an investigator for five years in Paris. Dr. Anh Wartel earned her MD at the Paris XII Medical School, France, and completed a post-graduate diploma in Public Health from the University of Liverpool, UK.

2012 was the year when Dr Lim became passionate about Regenerative medicine. He begins his timeless journey into a new world of Stem Cells discoveries and realised that Stem cells transplantation in general is only simple cultured cells which is not consistently effective, especially there were very limited evidence in animals with almost none in humans for anti-ageing and diseases. Dr. Michael Lim Ming Soon pioneered the 1st Allogeneic Stem Cell transplantation for the region of Asia Pacific in 2012 for Aesthetic medicine and using source from umbilical MSC and dental pulp MSC. Due to the limitations on results, he further developed his Cell Enhancement X Cad Int (CEXCI) product line treatment, that made breakthroughs in the world of anti-ageing and diseases intervention. He has done over 1000 CEXCI treatments, and he is currently the pacesetter in the region for Stem cell therapy. His experience in the field of stem cells technology has been amicable, achieving many successful cases clinically. The 1st miraculous breakthrough, was CEXCI successfully slow down and reverse significantly the ageing process of a human. Following breakthroughs, CEXCI was able to help improve more than 40 incurable diseases inclusive of complicated disease and some selected terminal cases. Dr Lim has been passionate in training and teaching as well. He has been training doctors ever since 2012 to present, in Malaysia, Singapore, Indonesia, Taiwan and China. He was also appointed as keynote speaker in 15 countries and 26 cities, presenting about Stem Cell Technology and its applications.

Dr. Ljudmila Stojanovich earned her Ph.D. in Medicine in 1999, with a thesis focused on "Neuropsychiatric manifestations in patients with Systemic Lupus Erythematosus." Throughout her illustrious career, Dr. Stojanovich has dedicated her research efforts to Systemic Lupus Erythematosus, Antiphospholipid Syndrome, and Vaccination in patients with Autoimmune Rheumatic diseases. She has authored three monographs and approximately 250 articles, covering various aspects of Autoimmune Rheumatic disorders, which have been published in international and domestic journals, as well as conference proceedings. Dr. Stojanovich holds positions on several Editorial Boards, including Lupus, and serves as a reviewer for esteemed journals such as "Cellular and Molecular Neurobiology." As an esteemed academic, Dr. Stojanovich mentors and supervises numerous post-doctoral students. She is a sought-after Invited Speaker for lectures in Congresses and Symposia, and has organized and chaired numerous Workshops, Seminars, and Symposia. Dr. Stojanovich also contributes significantly to international projects, including the European Forum on Antiphospholipid Antibodies and Multicenter studies on antiphospholipid antibodies, infections, and autoimmune diseases. Her contributions have been recognized through various honors and appointments, including EULAR Honorary Membership, membership in the American Association for the Advancement of Science, and appointments to the International Team of Medical Experts for APS (Hughes Syndrome). She has chaired international congresses and received prestigious grants for her outstanding research contributions. Dr. Stojanovich's impact extends beyond academia, as she actively participates in clinical trials and serves as a consultant for pharmaceutical companies like Eli Lilly and Company. She continues to contribute significantly to the field of Autoimmune Rheumatic disorders as a Guest Editor and Associate Editor for reputable journals. With an impressive h-index of 34 and over 4,700 citations, Dr. Ljudmila Stojanovich's expertise and contributions remain invaluable in advancing our understanding and treatment of Autoimmune Rheumatic diseases.

With more than thirty years of professional experience in the pharmaceutical industry holding senior positions in several multinational companies, Graeme has his first Degree in Biochemistry & Pharmacology and a PhD in Pharmacokinetics and Drug Metabolism. Currently, he is the CEO and Founder (2003) of PharSafer Associates Ltd, a Global CRO focussing on Pharmacovigilance; Medical Affairs; Training; Auditing; Regulatory Strategy, and IT Informatics with offices in the UK, EU; Africa, and India. PharSafer has clients in all seven continents ranging products ranging from Biologics; Advanced Therapies; Medical Devices; Vaccines and Cosmetics. Graeme has also worked on several different safety databases and medical information databases developing new systems to enhance patient safety. As a trainer, Graeme has run training courses since 2003 both F2F and remotely with over 7000 people trained in different aspects of vigilance and is also a part-time lecturer for the post-graduate Diploma in Pharmacovigilance at the University of Hertfordshire, UK. Graeme is a member of many professional bodies including TOPRA; DIA; RQA; PIPA and MAPs and is working with Industry and EU Regulatory Authorities on the implementation of new legislation in the EU concerning clinical trials.

Prof. Dr. Mazhar I. Khan’s research involved molecular epidemiology and pathogenesis of influenza virus infection. Currently, in his laboratory in developing and testing nanoparticle-based avian influenza (bird flu) and infectious bronchitis virus vaccines. He has long-term experience in the development and application of DNA probes, PCR, multiplex PCR, real-time PCR, and loop-mediated isothermal amplification (LAMP) methods for the rapid detection of viral pathogens in clinical samples. Have made significant contributions in the diagnostic field using DNA techniques in the identification of several pathogens of avian, animal, and human diseases since 1985. Have a mentor visiting international scientists from Asia, Europe, and South America. He has extensive knowledge of pathogenicity studies in embryos infected with the infectious bronchitis virus, a coronavirus, which causes stunting and embryo deformity before hatching. As a virologist, have extensive knowledge and research involved in the development of diagnostic tests and vaccines for the control of avian viral diseases.

Gisele Kaningini has always been passionate about healthcare and the challenges of supply chain management. As soon as she left university, she chose to specialize in the medical field, aware of the crucial importance of logistics in the distribution of healthcare products, particularly vaccines. Her career path bears witness to her commitment and growing expertise in the field. From her early days as an intern at INRB, where she learned the ins and outs of vaccine production and distribution, to her current position as Senior Logistician with the INRB, Gisele has acquired in-depth knowledge of logistics processes specific to the medical sector.

Prof. Gustavo Alberto Obando-Pereda is Head of Immunoinformatics Core of National University of Moquegua. He completed doctoral studies in Genetics and Molecular Biology in the area of Applied Immunology at UNICAMP. He is currently a research professor at the National University of Moquegua being the research topicals molecular mimicry and vaccinomics.

Dr. Seyed Reza Banihashemi is a Ph.D. in Clinical Immunology from Tarbiatmodares University in Tehran, Iran, and also a Vaccinologist. He is currently the deputy of R&D and Assistant Professor of the Immunology Department at Razi Vaccine and Serum Research Institute. He has extensive experience in vaccine research and development, with a focus on immune responses bacterial and viruses’ vaccines. . He is main researcher and developer of the RaziCov-Pars protein recombinant COVID-19 vaccine (the first intranasal covid-19 vaccine) and he is the manufacturer of the Nano emulsion adjuvant system related to this vaccine. He has published several research papers on topics such as vaccine development, immune response evaluation, and adjuvant and drug delivery system. He is also a reviewer for prestigious scientific journals in the field of microbiology and immunology.

Julissa Soto Latino Health Equity Consulting has been a leader in the field of vaccines and immunizations in Colorado and throughout the nation since the onset of the COVID-19 Pandemic. The deployment of her signature community-based intervention strategy, Cultural Validation, has already resulted in more than 30,000 vaccinations and the distribution of more than 130,000 COVID-19 testing kits and 100,000 masks. In fact, her strategies and techniques have earned numerous awards across the country. Governor Jared Polis proclaimed September 20, 2021 as “Julissa Soto Day,” for her efforts during the pandemic in Colorado, and in 2023, she received the Immunization Champions Award from the Association of Immunization Managers for the State of Colorado based on the recommendation from the Colorado Department of Health and Public Environment. She was also recognized with the 2023 Distinguished Service Award from the CU Anschutz Medical Campus, an Honorable Mention at the 2023 Immunization Neighborhood Immunization Champion Awards from the National Adult and Influenza Immunization Summit (NAIIS), the 2022 Award for Excellence in the Promotion of Health Equity from the Colorado Public Health Association, the 2022 Equity in Immunization Award from the National Coalition for Immunization Coalitions and Partnerships, the 2022 Big Shot of the Year Award from Immunize Colorado, and the 2022 Heroines of the Pandemic Award from Pikes Peak Women. She received accolades from U.S. Senators Michael Bennet and John Hickenlooper, as well as from many others. Over the last three years, Julissa Soto Latino Health Equity Consulting has organized and hosted more than 300 community-based vaccine clinics. This success comes from not only from Julissa Soto Latino Health Equity Consulting’s specialization in vaccines and immunizations, but also the CEO’s own personal and professional connection to communities that face health disparities and barriers to vaccine accessibility. As a Spanish-Speaking, first generation immigrant herself, Julissa is dedicated to forming genuine relationships with the communities she serves as well as the partners she works with; Her background and experience enable her to meet communities where they are and connect with them in culturally relevant languages and methods they can understand and relate to. Her ability to effectively engage diverse and underserved communities has also been widely recognized, earning the 2022 DEI Champions in Advocacy Award from the Colorado Springs Independent, Colorado Springs Business Journal, Southeast Express and Colorado Spring Military Newspaper Group, the 2022 Victor Smith Memorial Award from Colorado Cross-Disability Coalition, the 2017 Centers for Disease Control and Prevention (CDC) Best Practices Award, the 2016 People Who Make a Difference Award from Wells Fargo, and the 2015 William Funk Award for Building Stronger Communities from the Colorado Nonprofit Association. By combining her lived experience with more than twenty years of community-based health programming experience, Julissa Soto Latino Health Equity Consulting has also become a renowned expert in bridging the gap between providers and communities. Julissa Soto holds key positions as a Vaccine Community Advisory Member at University of Colorado’s Children’s Hospital and as a Cultural Advisory Board Member at Vaccinate Your Family – a national nonprofit agency that strives to protect people of all ages from vaccine-preventable diseases – and where she shares her extensive health equity expertise to aid in the development of outreach plans to increase pediatric COVID vaccine uptake in marginalized communities. She is also a member of the following organizations and workgroups: the Immunization Workgroup at the National Association of County and City Health Officials, the Health Equity Commission at the Colorado Department of Public Health and Environment, the Denver Catholic Medical Association, the National Hispanic Medical Association, the National Association of Community Health Workers, the Kansas Community Health Worker Coalition, the Conference for Immunization Coalitions and Partnerships National Coalition Conference Planning Committee, the Colorado Department of Health Care Policy and Finance Ambassador Team, the Colorado Suicide Prevention Commission, the Behavioral Health Equity Steering Committee at the United States Substance Abuse and Mental Health Services Administration (SAMHSA).

Dr. Diallo Mamadou Madiou is a seasoned pharmacist with extensive expertise in pharmacovigilance, encompassing notification, training, signal management, and proposing pharmacovigilance solutions. Holding the esteemed position of President of the Guinean Pharmacovigilance organization, Dr. Diallo is at the forefront of advancing pharmaceutical safety initiatives in Guinea. Fluent in French, Dr. Diallo primarily communicates in this language, leveraging it as a vital tool in his professional endeavors. Currently residing in Conakry, Republic of Guinea, Dr. Diallo is deeply committed to promoting pharmacovigilance practices and ensuring the safe and effective use of medications within his community and beyond.

Dr. Jean Mercier Ythier is a professor of economics at the University of Paris-Panthéon-Assas, France. He graduated from the Institute of Political Studies of Paris (PhD, 1989). He was also a graduate student at Harvard University (1986-87). He went notably through positions of invited research fellow at the University of Montréal (Québec, Canada), assistant professor and associate professor of economics at the University of Paris Panthéon-Sorbonne and professor of economics at the University of Lorraine (France). Prof. Jean Mercier Ythier's research interests include the theory of general competitive equilibrium, microeconomic theory, public economic theory, economic philosophy, altruism, ethics, and topics of economic anthropology.

Abdurrahaman Mangari is a highly accomplished individual with a diverse range of experiences and expertise. He received his training in Medical Microbiology at Bayero University, Kano, Nigeria.Abdurrahaman has been actively involved in various public health initiatives, and research programs throughout his career. He was recognized as a World Health Organization Fellow for his work on the COVID-19 Recovery for Routine Immunization Program. He also participated in the Health Literacy Leadership Program at the West African Institute of Public Health. His professional experience includes working at prestigious institutions such as the Infectious Diseases Hospital, where he contributed to divisions such as Serology, Clinical Microbiology, Histopathology, Chemical Pathology, and Haematology. He has also served at the Federal Ministry of Health in the Department of Health Planning, Research, and Statistics, where he worked in divisions such as International Cooperation, Health System Strengthening, Policy and Planning, Monitoring and Evaluation, and Research and Ethics. Additionally, Abdurrahaman has been associated with the Nigeria Centre for Disease Control, where he has worked in various departments including Public Health Laboratory Services, Health Emergency Preparedness and Response, Prevention Programs and Knowledge Management, and Surveillance and Epidemiology. He has also held the position of team leader for the National Rapid Response Team on COVID-19 at the African Centre for Disease Control and Prevention in Nigeria.Currently, Abdurrahaman serves as the Director of NGOs and International Relations at the Centre for Environmental and Public Health Research and Development, further emphasizing his dedication to public health and research. Abdurrahaman's contributions extend beyond Nigeria, as he has been involved in international collaborations and memberships. He has been a member of the Research Consortium on COVID-19 at the Nigeria Center for Disease Control and a member of the African-Canada Artificial Intelligence and Data Innovation Consortium. He has also been associated with organizations like Global Vaccine Research America, the World Health Organization, the Centers for Disease Control and Prevention (CDC), and the Institute of Allergy and Infectious Diseases in the United States.His memberships in various national and international bodies, such as the Nigerian Society for Microbiology (NSM), Microbiological Society of the United Kingdom (UK), Nigerian Biological Safety Association (NIBSA), Civil Society for Cancer Eradication in Nigeria (CSCEN), All Northern Nigerian Students Association, Eye 4 Africa, American Society for Cancer Eradication (ASCE), and American Society for Microbiology (ASM), demonstrate his commitment to professional networking and collaboration. In recognition of his exceptional work, Abdurrahaman was awarded an international award in the United States in 2019. Despite the COVID-19 travel restrictions, his achievements were acknowledged, and his work on Clinical and Pharmaceutical Microbiology was included in the list of winners. Further information about his award can be found at the provided. Abdurrahaman's academic achievements are also noteworthy, as he excelled in various subjects including Pathology, Virology, Pathogenic Bacteriology, Pharmaceutical Microbiology,Epidemiology, and Public Health. His research project on Tuberculosis and Pneumonia in northwest Nigeria earned him recognition as the overall best student.With his extensive knowledge and experience in the field of Medical Microbiology, Abdurrahaman Mangari is undoubtedly a valuable asset to development organizations and a strong advocate for public health initiatives.

Will be Updated Soon!!

Dr. Peng Ruan is an Associate Chief Physician specializing in Gastroenterology at Renmin Hospital of Wuhan University, China. With a Ph.D. in Internal Medicine from Wuhan University, he brings extensive expertise in hepatology. Dr. Ruan's diverse professional journey includes roles as a Resident Physician in General Internal Medicine and ICU, as well as leadership positions in Gastroenterology. He has also served as a Visiting Scholar at INSERM U1052, Université Claude Bernard, Lyon, France. Dr. Ruan's research focus encompasses the study of chimeric protein transcription of HBV integration sites and the detection of intrahepatic HBV cccDNA in chronic hepatitis B patients. His contributions have been supported by grants from the National Natural Science Fund of Hubei Province and the Shiyan Science Technology and Innovation Committee.

Dr. ALIMA Carolle is a dedicated Pharmacist with a focus on patient safety and the enhancement of pharmaceutical systems. Serving as Secretary General at the Cameroon Pharmacovigilance Society, Dr. Carolle is at the forefront of ensuring the safe use of medications within the region. With a distinguished career spanning four years, Dr. Carolle has amassed invaluable experience in various aspects of pharmaceutical management. Her expertise encompasses vaccine stock management, vaccine safety monitoring, and the implementation of hemovigilance activities, among other critical responsibilities. Dr. Corolle's commitment to advancing pharmaceutical practices extends beyond her professional roles. As the pioneering Secretary General of the Société Camerounaise de Pharmacovigilance, she has played a pivotal role in promoting pharmacovigilance initiatives and fostering collaboration within the pharmaceutical community. A prolific contributor to scientific seminars, Dr. carolle is recognized for her insightful presentations on patient safety and the quality of patient care. Her passion for improving healthcare outcomes underscores her dedication to ensuring the highest standards of pharmaceutical practice. Driven by a fervent desire to safeguard patient well-being, Dr. ALIMA NKENGUE Monique Carolle continues to make significant contributions to the field of pharmacovigilance, leaving an indelible mark on the healthcare landscape of Cameroon and beyond.

Ahmed Ibrahim Isa, born on September 18, 1969, in Funtua, Katsina State, Nigeria, is a highly regarded public servant with extensive experience in the Nigerian Public Service. Holding a diploma in Public and Private Law, a B.Sc. in Political Science, and an M.Sc. in Political Economy and Development Studies, he has made significant contributions throughout his career. Ahmed's career began in 1999, and he has served in various key roles, including at the Family Economic Advancement Programme (FEAP), National Poverty Eradication Programme (NAPEP), Budget Office of the Federation (BOF), Federal Ministry of Health, and the Office of the Head of the Civil Service of the Federation. Currently, he holds the position of Deputy Director and Special Assistant to the Permanent Secretary in the Ministry of Aviation and Aerospace Development. His impactful contributions span across pivotal Ministries, showcasing his administrative acumen and visionary leadership traits. Ahmed played a crucial role in the Presidential Committee on the Restructuring of the Nigeria Customs Service, contributing significantly to national development. With a focus on public health, Ahmed has actively participated in projects like the Nigeria State Health Investment Project (NSHIP) and represented Nigeria at international forums such as the World Health Assembly and the United Nations General Assembly. His commitment to organizational effectiveness is evident through his involvement in the National Council on Health and the Secretariat of the National Council on Establishments. Ahmed's tireless work ethic and leadership have set a standard of excellence, making him a respected figure in public administration in Nigeria. Currently serving as the Special Assistant to the Permanent Secretary at the Federal Ministry of Aviation and Aerospace Development, Ahmed continues to leave a lasting impact on the nation's governance and development.

Dr. Peter Averkiou is a pediatrician and an Associate Professor of Pediatrics at the Charles E. Schmidt College of Medicine at Florida Atlantic University. He is the Co-Director of the four Foundations of Medicine Courses, the Director of the Service Learning Projects, the Director of the Newborn Nursery Clinical Rotation and the Director of the Synthesis and Transition Course at the medical school.

DIALLO Aissatou Cira is a dedicated pharmacist who graduated from Mouhamed V Faculty of Medicine and Pharmacy in Rabat, part of the first class under the new regime. Her diverse internships included experiences in introductory and hospital pharmacies, as well as clinical pharmacy at Rabat Military Hospital. She also attended the annual Officine Expo in Marrakech, staying current with industry advancements. Aissatou has demonstrated leadership as treasurer and member of the scientific committee for the Association of Guinean Pupils, Students, and Trainees in Morocco (ASEGUIM Central) and the Association of Foreign Medical and Pharmacy Students in Rabat. Known for her motivation, dynamism, and sociability, Aissatou is passionate about her work, constantly seeking to innovate and learn.

Dr. Hossein Hosseinkhani, Biomedical Engineer, has 30 years of experience in biomedical engineering in both academia and industry in biomedical engineering research and development, which includes several years of basic science research experience in a number of premier institutions related to the structure and function of biomaterials, and in polymer-based medical implants development in the medical device industry. He is the inventor of 22 International patents, several of which are licensed to companies acting in the biomedical fields and translated to 7 commercial products. He authored more than 100 scientific papers published in peer-reviewed Journals, and 5 books (H-index: 48 Google Scholar). He is the founder of Matrix HT, Inc. a world-leading biotech company dedicated to healthcare technology to improve patient's quality of life.

I am Haftay Abraha Tadesse, I was Born and raised in Tigray, Northern Ethiopia and attended my primary education in Maynebri, secondary education in Adi-gudem Comprehensive Secondary School and Mekelle University for my undergraduate and graduate, MSc in Medical Microbiology and BSc in Animal Health. I have worked on the position of teaching and research in Mekelle universities in Ethiopia, currently teaching Molecular Biology, Microbiology and Biochemistry in Mekelle University, College of Veterinary Science. Besides, I have had experience on good laboratory of microbiology (food and Medical Microbiology), Public Health (Zoonosis food safety) and Molecular Biology. Furthermore, I am conducting of Microbiology and Molecular Biology (AMR and Drug screening) studies of different types stream.

An environmental engineer with a specialism in plant and computational informatics. A master's graduate in Mechanical and Manufacturing with a strong ability to communicate and relate in a working environment in a role. Has the ability to perform detailed analysis of complex data. Advanced technical skills include proficient use of AutoCAD, Autodesk Inventor, Solidworks, ExtendSim, Design of Experiments, Microsoft Office and other IT programs. Applies effectively and communicates in group skills during presentations to a wide range of engineers. Enjoys problem-solving, designing process improvements and striving for excellence. Has a desire to begin a challenging new role with the scope for further professional development; with particular interest in the areas of product development, production and manufacturing.

Chikezie Kennedy Kalu’s field of research is Technology and Innovation Management. He is from Nigeria and has a B.Eng. in Electronics Engineering from The University of Nigeria Nsukka; Nigeria (UNN) and a Masters (with Distinction) in Communication Engineering from The University of Manchester, UK. Chikezie has also presented his research works at various international conferences; he continues receiving more invites to share his works at international conferences and global webinars. He was also awarded the International Best Researcher in Management Science and Engineering at the Asia Research Awards (International Congress for Research Excellence 2024) in India, in March 2024.